Overview
Karen Selk is an Internal Medicine provider in Pittsburgh, Pennsylvania. Dr. Selk is rated as an Experienced provider by MediFind in the treatment of Postmenopausal Osteoporosis. Her top areas of expertise are Hypoparathyroidism, Osteoporosis, Postmenopausal Osteoporosis, and Type 1 Diabetes (T1D).
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 Locust St Ste 5120, Pittsburgh, PA 15219
400 Oxford Dr, Monroeville, PA 15146
Additional Areas of Focus
Dr. Selk has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Heritage Valley Multispecialty Group Inc
Stephanie Perry is a primary care provider, practicing in Internal Medicine in Beaver, Pennsylvania. Dr. Perry is rated as an Advanced provider by MediFind in the treatment of Postmenopausal Osteoporosis. Her top areas of expertise are High Cholesterol, Osteoporosis, Postmenopausal Osteoporosis, and Melorheostosis with Osteopoikilosis.
Heritage Valley Multispecialty Group Inc
Monica Farland is a primary care provider, practicing in Internal Medicine in Beaver, Pennsylvania. Dr. Farland is rated as an Advanced provider by MediFind in the treatment of Postmenopausal Osteoporosis. Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Hashimoto Thyroiditis, Breast Cancer, and Obesity in Children.
Heritage Valley Multispecialty Group Inc
Ashwini Gandhe is a primary care provider, practicing in Internal Medicine in Aliquippa, Pennsylvania. Dr. Gandhe is rated as an Advanced provider by MediFind in the treatment of Postmenopausal Osteoporosis. Her top areas of expertise are Anemia, Hypothyroidism, Obesity in Children, and Insomnia. Dr. Gandhe is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anaplastic Thyroid CancerDr. Selk isExperienced. Learn about Anaplastic Thyroid Cancer.
- Familial Hyperthyroidism due to Mutations in TSH Receptor
- Familial HypertriglyceridemiaDr. Selk isExperienced. Learn about Familial Hypertriglyceridemia.
- Familial Hypocalciuric Hypercalcemia Type 1
- Follicular Thyroid CancerDr. Selk isExperienced. Learn about Follicular Thyroid Cancer.
- Generalized Resistance to Thyroid Hormone